Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  



Oxycontin and nuisance

West Virginia's settlement two years ago with Purdue Pharma, maker of the drug Oxycontin, was alarming on numerous grounds; Prof. Childs, pointing to this student note (PDF) by Joseph B. Prater of Northwestern on the affair, observes that the case was "another step in efforts to make products liability cases into public nuisance cases". Guns and lead paint having already been assailed under nuisance theories, he wonders whether other pharmaceuticals will follow.



Isaac Gorodetski
Project Manager,
Center for Legal Policy at the
Manhattan Institute

Katherine Lazarski
Press Officer,
Manhattan Institute


Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.